Trends in Cardiovascular Mortality Among Patients With Alzheimer's Disease in the United States from 1999 to 2020
This study aimed to compare the trends in cardiovascular diseases (CVDs)-related mortality in patients with Alzheimer's disease (AD) and in the general population aged ≥65 years. Data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research Multipl...
Gespeichert in:
Veröffentlicht in: | The American journal of cardiology 2024-01, Vol.211, p.326-333 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 333 |
---|---|
container_issue | |
container_start_page | 326 |
container_title | The American journal of cardiology |
container_volume | 211 |
creator | Ranganathan, Sruthi Abramov, Dmitry Chew, Nicholas W S Mallen, Christian Marshall, Michelle Kobo, Ofer Mamas, Mamas A |
description | This study aimed to compare the trends in cardiovascular diseases (CVDs)-related mortality in patients with Alzheimer's disease (AD) and in the general population aged ≥65 years. Data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research Multiple Cause of Death dataset were used to determine national trends in age-adjusted CVD mortality rates (AAMR) and average annual percent change (AAPC) values in patients with AD and the overall population aged ≥65 years from 1999 to 2020. Data for AAMR and AAPCs were also stratified by age, gender, ethnicity/race, geographical region, urbanization status, and subgroups of CVD. Trends in the overall AAMR stratified by gender, age, ethnicity/race, geographical region, urbanization status, and CVD subgroups were statistically different between patients with AD and the overall population (overall AAPC for CVD mortality rate in patients with AD = -3.5% [confidence interval -4.1% to -2.9%] vs -2.6% [confidence interval -2.3% to -2.9%] in overall population, p = 0.01). Differences in the decrease in the mortality rates between patients with AD and the overall population were found to be statistically different across all stratifications except for the change in the mortality rates for hypertensive diseases (p = 0.05), females (p = 0.2), and Asian or Pacific Islanders (p = 0.09). In conclusion, CVD-related mortality in patients with AD decreased over the last 2 decades, and decreases were more prominent than seen in the general population aged ≥65 years. These results may help focus public health efforts to optimize CVD health in patients with AD. |
doi_str_mv | 10.1016/j.amjcard.2023.11.044 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2892946738</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2909638640</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-ae557cdc01aa08181425d1bf10971e89300b844e21598481708ef7d8f75a86df3</originalsourceid><addsrcrecordid>eNpdkVGL1DAUhYMo7uzqT1ACPuhL671N2iaPw6yuwoqCu_gYMu2tk9I2u0kqrL_eDDv64NPlwncOBz7GXiGUCNi8H0s7j50NfVlBJUrEEqR8wjaoWl2gRvGUbQCgKjRKfcbOYxzzi1g3z9mZaLUWIGHD7m8CLX3kbuG7XOb8Lxu7dbKBf_Eh2cmlB76d_fKTf7PJ0ZIi_-HSgW-n3wdyM4W3kV-6SDbSsSMdiN8uLlHPvyebKPIh-Jmj1ponz_NUeMGeDXaK9PJ0L9jtxw83u0_F9derz7vtddEJ0abCUl23Xd8BWgsKFcqq7nE_IOgWSeX5sFdSUoW1VlJhC4qGtldDW1vV9IO4YO8ee--Cv18pJjO72NE02YX8Gk2ldKVl0wqV0Tf_oaNfw5LXmUqDboRqJGSqfqS64GMMNJi74GYbHgyCOToxozk5MUcnBtFkJzn3-tS-7mfq_6X-ShB_AP86h5Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2909638640</pqid></control><display><type>article</type><title>Trends in Cardiovascular Mortality Among Patients With Alzheimer's Disease in the United States from 1999 to 2020</title><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central</source><creator>Ranganathan, Sruthi ; Abramov, Dmitry ; Chew, Nicholas W S ; Mallen, Christian ; Marshall, Michelle ; Kobo, Ofer ; Mamas, Mamas A</creator><creatorcontrib>Ranganathan, Sruthi ; Abramov, Dmitry ; Chew, Nicholas W S ; Mallen, Christian ; Marshall, Michelle ; Kobo, Ofer ; Mamas, Mamas A</creatorcontrib><description>This study aimed to compare the trends in cardiovascular diseases (CVDs)-related mortality in patients with Alzheimer's disease (AD) and in the general population aged ≥65 years. Data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research Multiple Cause of Death dataset were used to determine national trends in age-adjusted CVD mortality rates (AAMR) and average annual percent change (AAPC) values in patients with AD and the overall population aged ≥65 years from 1999 to 2020. Data for AAMR and AAPCs were also stratified by age, gender, ethnicity/race, geographical region, urbanization status, and subgroups of CVD. Trends in the overall AAMR stratified by gender, age, ethnicity/race, geographical region, urbanization status, and CVD subgroups were statistically different between patients with AD and the overall population (overall AAPC for CVD mortality rate in patients with AD = -3.5% [confidence interval -4.1% to -2.9%] vs -2.6% [confidence interval -2.3% to -2.9%] in overall population, p = 0.01). Differences in the decrease in the mortality rates between patients with AD and the overall population were found to be statistically different across all stratifications except for the change in the mortality rates for hypertensive diseases (p = 0.05), females (p = 0.2), and Asian or Pacific Islanders (p = 0.09). In conclusion, CVD-related mortality in patients with AD decreased over the last 2 decades, and decreases were more prominent than seen in the general population aged ≥65 years. These results may help focus public health efforts to optimize CVD health in patients with AD.</description><identifier>ISSN: 0002-9149</identifier><identifier>ISSN: 1879-1913</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2023.11.044</identifier><identifier>PMID: 37993040</identifier><language>eng</language><publisher>United States: Elsevier Limited</publisher><subject>Age ; Alzheimer's disease ; Apolipoproteins ; Cardiovascular diseases ; Dementia ; Disease control ; Epidemiology ; Ethnicity ; Gender ; Health risk assessment ; Hypertension ; Minority & ethnic groups ; Mortality ; Neurodegenerative diseases ; Pathogenesis ; Patients ; Population (statistical) ; Public health ; Race ; Risk factors ; Software ; Subgroups ; Trends ; Urbanization ; Womens health</subject><ispartof>The American journal of cardiology, 2024-01, Vol.211, p.326-333</ispartof><rights>Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</rights><rights>2023. The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-ae557cdc01aa08181425d1bf10971e89300b844e21598481708ef7d8f75a86df3</citedby><cites>FETCH-LOGICAL-c337t-ae557cdc01aa08181425d1bf10971e89300b844e21598481708ef7d8f75a86df3</cites><orcidid>0009-0003-0684-4263</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2909638640?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37993040$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ranganathan, Sruthi</creatorcontrib><creatorcontrib>Abramov, Dmitry</creatorcontrib><creatorcontrib>Chew, Nicholas W S</creatorcontrib><creatorcontrib>Mallen, Christian</creatorcontrib><creatorcontrib>Marshall, Michelle</creatorcontrib><creatorcontrib>Kobo, Ofer</creatorcontrib><creatorcontrib>Mamas, Mamas A</creatorcontrib><title>Trends in Cardiovascular Mortality Among Patients With Alzheimer's Disease in the United States from 1999 to 2020</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>This study aimed to compare the trends in cardiovascular diseases (CVDs)-related mortality in patients with Alzheimer's disease (AD) and in the general population aged ≥65 years. Data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research Multiple Cause of Death dataset were used to determine national trends in age-adjusted CVD mortality rates (AAMR) and average annual percent change (AAPC) values in patients with AD and the overall population aged ≥65 years from 1999 to 2020. Data for AAMR and AAPCs were also stratified by age, gender, ethnicity/race, geographical region, urbanization status, and subgroups of CVD. Trends in the overall AAMR stratified by gender, age, ethnicity/race, geographical region, urbanization status, and CVD subgroups were statistically different between patients with AD and the overall population (overall AAPC for CVD mortality rate in patients with AD = -3.5% [confidence interval -4.1% to -2.9%] vs -2.6% [confidence interval -2.3% to -2.9%] in overall population, p = 0.01). Differences in the decrease in the mortality rates between patients with AD and the overall population were found to be statistically different across all stratifications except for the change in the mortality rates for hypertensive diseases (p = 0.05), females (p = 0.2), and Asian or Pacific Islanders (p = 0.09). In conclusion, CVD-related mortality in patients with AD decreased over the last 2 decades, and decreases were more prominent than seen in the general population aged ≥65 years. These results may help focus public health efforts to optimize CVD health in patients with AD.</description><subject>Age</subject><subject>Alzheimer's disease</subject><subject>Apolipoproteins</subject><subject>Cardiovascular diseases</subject><subject>Dementia</subject><subject>Disease control</subject><subject>Epidemiology</subject><subject>Ethnicity</subject><subject>Gender</subject><subject>Health risk assessment</subject><subject>Hypertension</subject><subject>Minority & ethnic groups</subject><subject>Mortality</subject><subject>Neurodegenerative diseases</subject><subject>Pathogenesis</subject><subject>Patients</subject><subject>Population (statistical)</subject><subject>Public health</subject><subject>Race</subject><subject>Risk factors</subject><subject>Software</subject><subject>Subgroups</subject><subject>Trends</subject><subject>Urbanization</subject><subject>Womens health</subject><issn>0002-9149</issn><issn>1879-1913</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpdkVGL1DAUhYMo7uzqT1ACPuhL671N2iaPw6yuwoqCu_gYMu2tk9I2u0kqrL_eDDv64NPlwncOBz7GXiGUCNi8H0s7j50NfVlBJUrEEqR8wjaoWl2gRvGUbQCgKjRKfcbOYxzzi1g3z9mZaLUWIGHD7m8CLX3kbuG7XOb8Lxu7dbKBf_Eh2cmlB76d_fKTf7PJ0ZIi_-HSgW-n3wdyM4W3kV-6SDbSsSMdiN8uLlHPvyebKPIh-Jmj1ponz_NUeMGeDXaK9PJ0L9jtxw83u0_F9derz7vtddEJ0abCUl23Xd8BWgsKFcqq7nE_IOgWSeX5sFdSUoW1VlJhC4qGtldDW1vV9IO4YO8ee--Cv18pJjO72NE02YX8Gk2ldKVl0wqV0Tf_oaNfw5LXmUqDboRqJGSqfqS64GMMNJi74GYbHgyCOToxozk5MUcnBtFkJzn3-tS-7mfq_6X-ShB_AP86h5Q</recordid><startdate>20240115</startdate><enddate>20240115</enddate><creator>Ranganathan, Sruthi</creator><creator>Abramov, Dmitry</creator><creator>Chew, Nicholas W S</creator><creator>Mallen, Christian</creator><creator>Marshall, Michelle</creator><creator>Kobo, Ofer</creator><creator>Mamas, Mamas A</creator><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0003-0684-4263</orcidid></search><sort><creationdate>20240115</creationdate><title>Trends in Cardiovascular Mortality Among Patients With Alzheimer's Disease in the United States from 1999 to 2020</title><author>Ranganathan, Sruthi ; Abramov, Dmitry ; Chew, Nicholas W S ; Mallen, Christian ; Marshall, Michelle ; Kobo, Ofer ; Mamas, Mamas A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-ae557cdc01aa08181425d1bf10971e89300b844e21598481708ef7d8f75a86df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Age</topic><topic>Alzheimer's disease</topic><topic>Apolipoproteins</topic><topic>Cardiovascular diseases</topic><topic>Dementia</topic><topic>Disease control</topic><topic>Epidemiology</topic><topic>Ethnicity</topic><topic>Gender</topic><topic>Health risk assessment</topic><topic>Hypertension</topic><topic>Minority & ethnic groups</topic><topic>Mortality</topic><topic>Neurodegenerative diseases</topic><topic>Pathogenesis</topic><topic>Patients</topic><topic>Population (statistical)</topic><topic>Public health</topic><topic>Race</topic><topic>Risk factors</topic><topic>Software</topic><topic>Subgroups</topic><topic>Trends</topic><topic>Urbanization</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ranganathan, Sruthi</creatorcontrib><creatorcontrib>Abramov, Dmitry</creatorcontrib><creatorcontrib>Chew, Nicholas W S</creatorcontrib><creatorcontrib>Mallen, Christian</creatorcontrib><creatorcontrib>Marshall, Michelle</creatorcontrib><creatorcontrib>Kobo, Ofer</creatorcontrib><creatorcontrib>Mamas, Mamas A</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ranganathan, Sruthi</au><au>Abramov, Dmitry</au><au>Chew, Nicholas W S</au><au>Mallen, Christian</au><au>Marshall, Michelle</au><au>Kobo, Ofer</au><au>Mamas, Mamas A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in Cardiovascular Mortality Among Patients With Alzheimer's Disease in the United States from 1999 to 2020</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2024-01-15</date><risdate>2024</risdate><volume>211</volume><spage>326</spage><epage>333</epage><pages>326-333</pages><issn>0002-9149</issn><issn>1879-1913</issn><eissn>1879-1913</eissn><abstract>This study aimed to compare the trends in cardiovascular diseases (CVDs)-related mortality in patients with Alzheimer's disease (AD) and in the general population aged ≥65 years. Data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research Multiple Cause of Death dataset were used to determine national trends in age-adjusted CVD mortality rates (AAMR) and average annual percent change (AAPC) values in patients with AD and the overall population aged ≥65 years from 1999 to 2020. Data for AAMR and AAPCs were also stratified by age, gender, ethnicity/race, geographical region, urbanization status, and subgroups of CVD. Trends in the overall AAMR stratified by gender, age, ethnicity/race, geographical region, urbanization status, and CVD subgroups were statistically different between patients with AD and the overall population (overall AAPC for CVD mortality rate in patients with AD = -3.5% [confidence interval -4.1% to -2.9%] vs -2.6% [confidence interval -2.3% to -2.9%] in overall population, p = 0.01). Differences in the decrease in the mortality rates between patients with AD and the overall population were found to be statistically different across all stratifications except for the change in the mortality rates for hypertensive diseases (p = 0.05), females (p = 0.2), and Asian or Pacific Islanders (p = 0.09). In conclusion, CVD-related mortality in patients with AD decreased over the last 2 decades, and decreases were more prominent than seen in the general population aged ≥65 years. These results may help focus public health efforts to optimize CVD health in patients with AD.</abstract><cop>United States</cop><pub>Elsevier Limited</pub><pmid>37993040</pmid><doi>10.1016/j.amjcard.2023.11.044</doi><tpages>8</tpages><orcidid>https://orcid.org/0009-0003-0684-4263</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9149 |
ispartof | The American journal of cardiology, 2024-01, Vol.211, p.326-333 |
issn | 0002-9149 1879-1913 1879-1913 |
language | eng |
recordid | cdi_proquest_miscellaneous_2892946738 |
source | Elsevier ScienceDirect Journals Complete; ProQuest Central |
subjects | Age Alzheimer's disease Apolipoproteins Cardiovascular diseases Dementia Disease control Epidemiology Ethnicity Gender Health risk assessment Hypertension Minority & ethnic groups Mortality Neurodegenerative diseases Pathogenesis Patients Population (statistical) Public health Race Risk factors Software Subgroups Trends Urbanization Womens health |
title | Trends in Cardiovascular Mortality Among Patients With Alzheimer's Disease in the United States from 1999 to 2020 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A19%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20Cardiovascular%20Mortality%20Among%20Patients%20With%20Alzheimer's%20Disease%20in%20the%20United%20States%20from%201999%20to%202020&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Ranganathan,%20Sruthi&rft.date=2024-01-15&rft.volume=211&rft.spage=326&rft.epage=333&rft.pages=326-333&rft.issn=0002-9149&rft.eissn=1879-1913&rft_id=info:doi/10.1016/j.amjcard.2023.11.044&rft_dat=%3Cproquest_cross%3E2909638640%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2909638640&rft_id=info:pmid/37993040&rfr_iscdi=true |